GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Savara Inc (NAS:SVRA) » Definitions » E10

Savara (Savara) E10 : $-5.91 (As of Mar. 2024)


View and export this data going back to 1996. Start your Free Trial

What is Savara E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Savara's adjusted earnings per share data for the three months ended in Mar. 2024 was $-0.110. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-5.91 for the trailing ten years ended in Mar. 2024.

During the past 3 years, the average E10 Growth Rate was 23.30% per year. During the past 5 years, the average E10 Growth Rate was 37.10% per year. During the past 10 years, the average E10 Growth Rate was 36.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Savara was 54.20% per year. The lowest was 6.60% per year. And the median was 25.30% per year.

As of today (2024-05-14), Savara's current stock price is $4.81. Savara's E10 for the quarter that ended in Mar. 2024 was $-5.91. Savara's Shiller PE Ratio of today is .


Savara E10 Historical Data

The historical data trend for Savara's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Savara E10 Chart

Savara Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -23.36 -14.31 -11.29 -8.97 -6.45

Savara Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -8.04 -7.31 -6.92 -6.45 -5.91

Competitive Comparison of Savara's E10

For the Biotechnology subindustry, Savara's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Savara's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Savara's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Savara's Shiller PE Ratio falls into.



Savara E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Savara's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.11/129.4194*129.4194
=-0.110

Current CPI (Mar. 2024) = 129.4194.

Savara Quarterly Data

per share eps CPI Adj_EPS
201406 -4.200 100.560 -5.405
201409 -4.200 100.428 -5.412
201412 -3.500 99.070 -4.572
201503 -4.200 99.621 -5.456
201506 -4.200 100.684 -5.399
201509 -4.200 100.392 -5.414
201512 -4.200 99.792 -5.447
201603 -4.404 100.470 -5.673
201606 -1.970 101.688 -2.507
201609 -1.210 101.861 -1.537
201612 -1.400 101.863 -1.779
201703 -1.650 102.862 -2.076
201706 -0.900 103.349 -1.127
201709 -0.280 104.136 -0.348
201712 -0.230 104.011 -0.286
201803 -0.860 105.290 -1.057
201806 -0.370 106.317 -0.450
201809 -0.360 106.507 -0.437
201812 -0.290 105.998 -0.354
201903 -0.340 107.251 -0.410
201906 -0.570 108.070 -0.683
201909 -0.300 108.329 -0.358
201912 -0.720 108.420 -0.859
202003 -0.270 108.902 -0.321
202006 -0.160 108.767 -0.190
202009 -0.180 109.815 -0.212
202012 -0.230 109.897 -0.271
202103 -0.130 111.754 -0.151
202106 -0.070 114.631 -0.079
202109 -0.070 115.734 -0.078
202112 -0.070 117.630 -0.077
202203 -0.050 121.301 -0.053
202206 -0.060 125.017 -0.062
202209 -0.070 125.227 -0.072
202212 -0.070 125.222 -0.072
202303 -0.070 127.348 -0.071
202306 -0.070 128.729 -0.070
202309 -0.100 129.860 -0.100
202312 -0.090 129.419 -0.090
202403 -0.110 129.419 -0.110

Add all the adjusted EPS together and divide 10 will get our e10.


Savara  (NAS:SVRA) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Savara E10 Related Terms

Thank you for viewing the detailed overview of Savara's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Savara (Savara) Business Description

Traded in Other Exchanges
Address
6836 Bee Cave Road, Building I, Suite 205, Austin, TX, USA, 78746
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's lead program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.
Executives
Matthew Pauls director 9 DEER PARK DRIVE, SUITE C, MONMOUTH JUNCTION NJ 08852
David L Lowrance officer: Chief Financial Officer 422 WILLIAM WALLACE DRIVE, FRANKLIN TN 37064
Nevan C Elam director C/O NEKTAR THERAPEUTICS, 150 INDUSTRIAL ROAD, SAN CARLOS CA 94070
Rick Yang 10 percent owner 2855 SAND HILL ROAD, MENLO PARK CA 94025
Scott D Sandell 10 percent owner
Forest Baskett 10 percent owner
Florence Anthony A. Jr. 10 percent owner 5425 WISCONSIN AVENUE, SUITE 800, CHEVY CHASE MD 20815
Ali Behbahani 10 percent owner 5425 WISCONSIN AVE, CHEVY CHASE MD 20815
Mohamad Makhzoumi 10 percent owner 2855 SAND HILL ROAD, MENLO PARK CA 94025
Paul Edward Walker 10 percent owner 1954 GREENSPRING DRIVE, SUITE 600, TIMONIUM MD 21093
Carmen Chang 10 percent owner 2855 SAND HILL ROAD, MENLO PARK CA 94025
Edward T Mathers 10 percent owner C/O MEDIMMUNE, INC., ONE MEDIMMUNE WAY, GAITHERSBURG MD 20878
Growth Equity Opportunities 17, Llc 10 percent owner 1954 GREENSPRING DRIVE, SUITE 600, TIMONIUM MD 21093
Raymond Dennis Pratt officer: Chief Medical Officer 208 E CHASE ST, BALTIMORE MD 21202
David A Ramsay director HALOZYME THERAPEUTICS, INC., 11588 SORRENTO VALLEY ROAD, #17, SAN DIEGO CA 92121

Savara (Savara) Headlines